The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Pulmonary Arterial Hypertension Is Linked to Insulin Resistance and Reversed by Peroxisome Proliferator–Activated Receptor-γ Activation
Abstract
Background— Patients with pulmonary arterial hypertension (PAH) have reduced expression of apolipoprotein E (apoE) and peroxisome proliferator–activated receptor-γ in lung tissues, and deficiency of both has been linked to insulin resistance. ApoE deficiency leads to enhanced platelet-derived growth factor signaling, which is important in the pathobiology of PAH. We therefore hypothesized that insulin-resistant apoE-deficient (apoE −/− ) mice would develop PAH that could be reversed by a peroxisome proliferator–activated receptor-γ agonist (eg, rosiglitazone). Methods and Results— We report that apoE −/− mice on a high-fat diet develop PAH as judged by elevated right ventricular systolic pressure. Compared with females, male apoE −/− were insulin resistant, had lower plasma adiponectin, and had higher right ventricular systolic pressure associated with right ventricular hypertrophy and increased peripheral pulmonary artery muscularization. Because male apoE −/− mice were insulin resistant and had more severe PAH than female apoE −/− mice, we treated them with rosiglitazone for 4 and 10 weeks. This treatment resulted in markedly higher plasma adiponectin, improved insulin sensitivity, and complete regression of PAH, right ventricular hypertrophy, and abnormal pulmonary artery muscularization in male apoE −/− mice. We further show that recombinant apoE and adiponectin suppress platelet-derived growth factor-BB–mediated proliferation of pulmonary artery smooth muscle cells harvested from apoE −/− or C57Bl/6 control mice. Conclusions— We have shown that insulin resistance, low plasma adiponectin levels, and deficiency of apoE may be risk factors for PAH and that peroxisome proliferator–activated receptor-γ activation can reverse PAH in an animal model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Obesity and the Metabolic Syndrome in Children and Adolescents
Weiss, R., Dziura, J., Burgert, T. S., Tamborlane, W. V., Taksali, S. E., Yeckel, C. W., Allen, K., Lopes, M., Savoye, M., Morrison, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031049 · Cited by 3,459
Teichholz, L. E., Kreulen, T., Herman, M. V., & Gorlin, R. (1976) · The American Journal of Cardiology · doi:10.1016/0002-9149(76)90491-4 · Cited by 2,571
Fitzgerald, M., Hayward, I. P., Thomas, A. C., Campbell, J. H., & CAMPBELL, G. R. (1995) · Cited by 2,552
Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
Giaid, A., Yanagisawa, M., Langleben, D., Michel, R. P., Levy, R., Shennib, H., Kimura, S., Masaki, T., Duguid, W. P., & Stewart, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282402 · Cited by 1,842
Self-citationTei, C., Ling, L. H., Hodge, D. O., Bailey, K. R., Oh, J. K., Rodeheffer, R. J., Tajik, A. J., & Seward, J. B. (1995) · PubMed · Cited by 1,547
Lane, K. B., Machado, R. D., Pauciulo, M. W., Thomson, J. R., Phillips, J. A., Loyd, J. E., Nichols, W. C., & Trembath, R. C. (2000) · Nature Genetics · doi:10.1038/79226 · Cited by 1,495
Lehrke, M., & Lazar, M. A. (2005) · Cell · doi:10.1016/j.cell.2005.11.026 · Cited by 1,443
Grundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Adiponectin and protection against type 2 diabetes mellitus
Spranger, J., Kroke, A., Möhlig, M., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12255-6 · Cited by 1,120
Reversal of experimental pulmonary hypertension by PDGF inhibition
Schermuly, R. T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24838 · Cited by 1,058
He, W., Barak, Y., Hevener, A., Olson, P., Liao, D., Le, J., Nelson, M., Ong, E., Olefsky, J. M., & Evans, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536828100 · Cited by 976
Humbert, M., Monti, G., Brenot, F., Sitbon, O., Portier, A., Grangeot-Keros, L., Duroux, P., Galanaud, P., Simonneau, G., & Emilie, D. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.5.7735624 · Cited by 797
Arita, Y., Kihara, S., Ouchi, N., Maeda, K., Kuriyama, H., Okamoto, Y., Kumada, M., Hotta, K., Nishida, M., Takahashi, M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000018622.84402.ff · Cited by 695
Tilson, M. D. (2005) · Circulation · doi:10.1161/circulationaha.105.553370 · Cited by 654
Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor
Stühlinger, M. C. (2002) · JAMA · doi:10.1001/jama.287.11.1420 · Cited by 581
LRP: Role in Vascular Wall Integrity and Protection from Atherosclerosis
Boucher, P., Gotthardt, M., Li, W.-P., Anderson, R. G. W., & Herz, J. (2003) · Science · doi:10.1126/science.1082095 · Cited by 581
Yudkin, J. S., Eringa, E., & Stehouwer, C. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66585-3 · Cited by 549
Marx, N., Duez, H., Fruchart, J.-C., & Staels, B. (2004) · Circulation Research · doi:10.1161/01.res.0000127122.22685.0a · Cited by 501
Imatinib for the Treatment of Pulmonary Arterial Hypertension
Ghofrani, H. A., Seeger, W., & Grimminger, F. (2005) · New England Journal of Medicine · doi:10.1056/nejmc051946 · Cited by 492
Muscle-specific Pparg deletion causes insulin resistance
Hevener, A. L., He, W., Barak, Y., Le, J., Bandyopadhyay, G., Olson, P., Wilkes, J., Evans, R. M., & Olefsky, J. (2003) · Nature Medicine · doi:10.1038/nm956 · Cited by 492
Combs, C. K., Johnson, D. E., Karlo, J. C., Cannady, S. B., & Landreth, G. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00558.2000 · Cited by 483
Expression and Function of PPARγ in Rat and Human Vascular Smooth Muscle Cells
Law, R. E., Goetze, S., Xi, X.-P., Jackson, S., Kawano, Y., Demer, L., Fishbein, M. C., Meehan, W. P., & Hsueh, W. A. (2000) · Circulation · doi:10.1161/01.cir.101.11.1311 · Cited by 442
Xu, A., Chan, K. W., Hoo, R. L. C., Wang, Y., Tan, K. C. B., Zhang, J., Chen, B., Lam, M. C., Tse, C., Cooper, G. J. S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414231200 · Cited by 419
Wang, Y., Lam, K. S. L., Xu, J. Y., Lu, G., Xu, L. Y., Cooper, G. J. S., & Xu, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501149200 · Cited by 380
Humbert, M., Monti, G., Fartoukh, M., Magnan, A., Brenot, F., Rain, B., Capron, F., Galanaud, P., Duroux, P., Simonneau, G., et al. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11030554 · Cited by 306
Ameshima, S., Golpon, H., Cool, C. D., Chan, D., Vandivier, R. W., Gardai, S. J., Wick, M., Nemenoff, R. A., Geraci, M. W., & Voelkel, N. F. (2003) · Circulation Research · doi:10.1161/01.res.0000073585.50092.14 · Cited by 292
CX 3 C Chemokine Fractalkine in Pulmonary Arterial Hypertension
Balabanian, K., Foussat, A., Dorfmüller, P., Durand-Gasselin, I., Capel, F., Bouchet-Delbos, L., Portier, A., Marfaing-Koka, A., Krzysiek, R., Rimaniol, A.-C., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2106007 · Cited by 274
Geraci, M. W., Moore, M., Gesell, T., Yeager, M. E., Alger, L., Golpon, H., Gao, B., Loyd, J. E., Tuder, R. M., & Voelkel, N. F. (2001) · Circulation Research · doi:10.1161/01.res.88.6.555 · Cited by 267
West, J., Fagan, K., Steudel, W., Fouty, B., Lane, K., Harral, J., Hoedt-Miller, M., Tada, Y., Ozimek, J., Tuder, R., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000126047.82846.20 · Cited by 263
St. John Sutton, M., Rendell, M., Dandona, P., Dole, J. F., Murphy, K., Patwardhan, R., Patel, J., Freed, M., & For the Rosiglitazone Clinical Trials Study Group (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2058 · Cited by 254
Merklinger, S. L., Jones, P. L., Martinez, E. C., & Rabinovitch, M. (2005) · Circulation · doi:10.1161/circulationaha.105.540542 · Cited by 245
Self-citationThe key role of apolipoprotein E in atherosclerosis
Greenow, K., Pearce, N. J., & Ramji, D. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0631-3 · Cited by 237
Asymmetrical Dimethylarginine in Idiopathic Pulmonary Arterial Hypertension
Kielstein, J. T., Bode-Böger, S. M., Hesse, G., Martens-Lobenhoffer, J., Takacs, A., Fliser, D., & Hoeper, M. M. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000168414.06853.f0 · Cited by 220
Guignabert, C., Izikki, M., Tu, L. I., Li, Z., Zadigue, P., Barlier-Mur, A.-M., Hanoun, N., Rodman, D., Hamon, M., Adnot, S., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000222546.45372.a0 · Cited by 196
Zaidi, S. H. E., You, X.-M., Ciura, S., Husain, M., & Rabinovitch, M. (2002) · Circulation · doi:10.1161/hc0402.102866 · Cited by 186
Self-citationIshigami, M., Swertfeger, D. K., Granholm, N. A., & Hui, D. Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20156 · Cited by 144
Imatinib Attenuates Diabetes-Associated Atherosclerosis
Lassila, M., Allen, T. J., Cao, Z., Thallas, V., Jandeleit-Dahm, K. A. M., Candido, R., & Cooper, M. E. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000124105.39900.db · Cited by 142
The Pathology of the Pulmonary Vasculature.
(1964) · Annals of Internal Medicine · doi:10.7326/0003-4819-61-1-168_1 · Cited by 130
Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats
Ikeda, Y., Yonemitsu, Y., Kataoka, C., Kitamoto, S., Yamaoka, T., Nishida, K.-I., Takeshita, A., Egashira, K., & Sueishi, K. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00919.2001 · Cited by 114
Newton, C. S., Loukinova, E. B., MIKHAILENKO, I. A., Ranganathan, S., Gao, Y., Haudenschild, C. C., & Strickland, D. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505410200 · Cited by 94
Bruemmer, D., Yin, F., Liu, J., Berger, J. P., Sakai, T., Blaschke, F., Fleck, E., Herle, A. J. V., FORMAN, B. M., & Law, R. E. (2003) · Circulation Research · doi:10.1161/01.res.0000088344.15288.e6 · Cited by 93
Martin‐Nizard, F., Furman, C., Delerive, P., Kandoussi, A., Fruchart, J., Staels, B., & Duriez, P. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200212000-00003 · Cited by 90
The humoral side of insulin resistance
Lazar, M. A. (2006) · Nature Medicine · doi:10.1038/nm0106-43 · Cited by 84
Phillips, J. W., Barringhaus, K. G., Sanders, J. M., Yang, Z., Chen, M., Hesselbacher, S. E., Czarnik, A. C., Ley, K. F., Nadler, J. L., & Sarembock, I. J. (2003) · Circulation · doi:10.1161/01.cir.0000092886.52404.50 · Cited by 81
Wakino, S., Kintscher, U., Liu, Z., Kim, S., Yin, F., Ohba, M., Kuroki, T., Schönthal, A. H., Hsueh, W. A., & Law, R. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108719200 · Cited by 72
Gauthier, A., Vassiliou, G., Benoist, F., & McPherson, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212989200 · Cited by 66
LRP and PDGF Signaling: A Pathway to Atherosclerosis
Boucher, P., & Gotthardt, M. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2003.12.001 · Cited by 59
Systematic Evaluation of Anti-apoptotic Growth Factor Signaling in Vascular Smooth Muscle Cells
Vantler, M., Caglayan, E., Zimmermann, W., Bäumer, A. T., & Rosenkranz, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413310200 · Cited by 57
Goetze, S., Kintscher, U., Kim, S., Meehan, W. P., Kaneshiro, K., Collins, A. R., Fleck, E., Hsueh, W. A., & Law, R. E. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200112000-00013 · Cited by 57
p27Kip1 Is Important in Modulating Pulmonary Artery Smooth Muscle Cell Proliferation
Fouty, B., Grimison, B., Fagan, K. A., Cras, T. D. L., Harral, J. W., Hoedt-Miller, M., Sclafani, R. A., & Rodman, D. M. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.5.4592 · Cited by 56
Campbell, M., Allen, W. E., Silversides, J. A., & Trimble, E. R. (2003) · Diabetes · doi:10.2337/diabetes.52.2.519 · Cited by 48
Comparison of the Tei index with invasive measurements of right ventricular function
Grignola, J. C., Ginés, F., & Guzzo, D. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.10.012 · Cited by 42
Zhang, J., Fu, M., Zhao, L., & Chen, Y. E. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02401-4 · Cited by 26
Imaizumi, T., Matsumiya, T., Tamo, W., Shibata, T., Fujimoto, K., Kumagai, M., Yoshida, H., Cui, X., Tanji, K., Hatakeyama, M., et al. (2002) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2002.01111.x · Cited by 24
Ueshima, K., Akihisa-Umeno, H., Nagayoshi, A., Takakura, S., Matsuo, M., & Mutoh, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.014 · Cited by 13
Cited by
Role of platelet-derived growth factors in physiology and medicine
Andrae, J., Gallini, R., & Betsholtz, C. (2008) · Genes & Development · doi:10.1101/gad.1653708 · Cited by 2,438
Molecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33452 · Cited by 880
Self-citationMechanisms of disease: pulmonary arterial hypertension
Schermuly, R. T., Ghofrani, H. A., Wilkins, M. R., & Grimminger, F. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.87 · Cited by 800
Pulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 664
Molecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60658 · Cited by 653
Self-citation
Metadata
- Authors
- Hansmann, G., Wagner, R. A., Schellong, S., de Jesus Perez, V. A., Urashima, T., Wang, L., Sheikh, A. Y., Suen, R. S., Stewart, D. J., & Rabinovitch, M.
- Venue
- Circulation
- Published
- 2007-03-13
- Volume
- 115
- Issue
- 10
- Pages
- 1275-1284
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2088829415
- Cited by
- 366
- References
- 58
- FWCI
- 15.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.